Development and validation of a diagnostic nomogram integrating anatomical scores and systemic immune-inflammatory biomarkers for De Novo metastatic renal cell carcinoma.
Combining anatomy scans with blood immune markers creates a more accurate tool for identifying advanced kidney cancer at diagnosis.
Researchers developed and validated a diagnostic nomogram that integrates anatomical scores with systemic immune-inflammatory biomarkers for identifying de novo metastatic renal cell carcinoma. The model showed promising diagnostic performance in a single-center retrospective cohort.
What the study was
- Study design
- Retrospective diagnostic validation study
- Population
- De novo metastatic renal cell carcinoma patients
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Frontiers in immunology
Why it surfaced
Validated diagnostic nomogram for metastatic RCC. Single-center retrospective design.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.